Navigation Links
China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
Date:9/17/2008

TAIAN CITY, Shandong, China, Sept. 17 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company received approval from the PRC State Food and Drug Administration (the "SFDA") to commence clinical trial of its new Human Coagulation Factor VIII product ("FVIII"), a coagulation treatment for hemophilia and mass hemorrhaging.

As one of four suppliers of Cryoprecipitate in China, China Biologic has been engaged in a contract to supply Cryoprecipitate to Green Cross China for use in the production of FVIII. With its own supply of Cryoprecipitate and its continued research and development of FVIII, the Company has obtained approval to commence clinical trial for 200 IU and 300 IU per dose of FVIII.

China Biologic has commenced preparations for the clinical study and expects to receive results by mid-2009. If the clinical study is successful, management expects to get SFDA's approval for production to launch the product at the beginning of 2010.

"We are pleased that our continued focus on research and development has led us to receive approval from the SFDA for clinical trial of FVIII," said Mr. Chao Ming Zhao, the Company's CEO. "The approval represents a significant milestone on diversifying our product portfolio. In addition, we believe our ability to produce Cryoprecipitate from clinical extra plasma - plasma that would have been discarded previously - will yield a higher gross profit margin in the production of FVIII."

About China Biologic Products, Inc.

Through its indirect majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd., China Biologic Products, Inc. (the "Company"), is principally engaged in the research, development, production and manufacturing and sale of plasma-based biopharmaceutical products to h
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., Nov. 6 BioSpecifics Te...ical company developing first-in-class collagenase...ults for the third quarter ended September 30, 200...ber of this year, the FDA,s Arthritis Advisory Com... the approval of XIAFLEX(TM) for the treatment of ...
(Date:11/6/2009)...stria, November 6 EUCODIS Bioscien...ng, and marketing enzymes for the,chemical industr...rch,agreement with Bio Sidus, the leading biopharm... agreement gives EUCODIS Bioscience exclusive acce...o Sidus, proprietary collection of,psychrophilic b...
(Date:11/6/2009)...6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc....any") today announced updated results from a Phase...ith sarcomas metastatic to the lung in a poster pr...cology Society Meeting held in Miami Beach, Florid...on, entitled "A Phase II Study of Intravenous REOL...
(Date:11/5/2009)...-- Gone hybrid . . . , Fuel economy ratings fo...ed at the www.fueleconomy.gov web site, which Oa...s for the U.S. Department of Energy and the U.S. E... vehicles on the best fuel economy list are hybrid...48 highway). "This list proves that hybrids have g...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...iences Inc. today announced the development of a u...g from tissue hydration to the passivation of medi...is a series of patent-pending polymers that allow ... angle," says Andrew Loxley, PS, Director of New T...ed the system to develop an ocular formulation for...
...chnology today announced,that the company has obta...utilize Merck Eprova,s proprietary chiral lipid DO...ts in development based on the Versamune(TM),techn...oride shows enhanced,adjuvant activity compared to...enantiomerically pure DOTAP Chloride manufactured ...
...ork Sciences, Inc. (GNS) today announced that it h...Executive Officer of Stromedix, Inc. and former Ex... to its Board of Directors. , , Dr. Gilman has ...dix since June 2006. He was previously Executive ... Biogen in 1999 as Director of Molecular Biology a...
Other Biology Technology:Particle Sciences Completes Development of First Product Incorporating its Unique Surface Modification System 2PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies 2Gene Network Sciences Announces Michael Gilman as Board Member 2
(Date:11/4/2009)...ass., Oct. 20 Aware, Inc...d technology and biometrics software, today report...September 30, 2009. ,, Michael Tzannes, Aware...rlier today, we announced an agreement to sell our...a new fabless semiconductor company being spun out...
(Date:11/4/2009)..., Oct. 26 BIO-key Intern... in finger-based biometric identification software...s at the AABB TXPO conference being held at the Ne...9. BIO-key will provide hands-on product demonstra...ology in booth #424. Also, at 5 PM on Monday, Octo...
(Date:11/4/2009)...Calif., Nov. 4 GenVault Corporatio...y, M.D., Ph.D., has joined its Board of Directors....f the Salk Institute, is an acclaimed physician-sc...he Salk Institute, Dr. Brody served as president o... the National Academy of Engineering and the Insti...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7BIO-key(R) International Exhibiting at AABB TXPO 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Susies Big Adventure Explores Plastic Surgery In Saudi Arabia 53959 1Beetroot Juice May Boost Stamina 53957 1Beetroot Juice May Boost Stamina 53957 2School Closures May Not Be Necessary When Swine Flu Strikes 53955 1School Closures May Not Be Necessary When Swine Flu Strikes 53955 2School Closures May Not Be Necessary When Swine Flu Strikes 53955 3School Closures May Not Be Necessary When Swine Flu Strikes 53955 4
..., Mass. (Oct. 20, 2008) -- Two teams of scientists...echnology (HST) at Brigham and Women,s Hospital ha...elivery system that is biocompatible, efficient at...ese structures can deliver clinically approved dru...rs for the drug or generating toxic components, a ...
...chers are on the verge of unleashing the power of ... therapies, as decades of research begins to bear ... best kept secrets, but is now attracting fast gro...rmaceutical industry in the quest for novel drugs ...lly overcoming limitations and side effects of cur...
...thers purposely expose their offspring to their ow...use it is widely accepted that exposure to materna...ative impacts on offspring following birth. To exa...pen, evolutionary physiologists Oliver Love and To... maternally-derived stress hormone corticosterone ...
Other Biology News:European researchers harness unique properties of boron to develop new drugs and diagnostics 2European researchers harness unique properties of boron to develop new drugs and diagnostics 3Exposing chicks to maternal stress leads to long-term reproductive success 2
Rabbit Anti-CRIPT Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...quadrupole 1200L sets the new standard for value i...ng the latest technologies and providing tailored ... needs. The Atmospheric Pressure Ionization (API)...r provide superior selectivity and sensitivity for...
Goat Anti-Human Legumain Polyclonal Antibodies, from R&D Systems
Rat Anti-Mouse Endoglin Monoclonal Antibody, Fluorescein Conjugated, Clone 209701 from R&D Systems
Biology Products: